Defining long COVID using a population-based SARS-CoV-2 survey in California.
dc.contributor.affiliation | California Department of Public Health, Richmond, CA, USA; School of Medicine, University of California, Davis, CA, USA; Center for Infectious Disease Research in Zambia, Lusaka, Zambia. Electronic address: jmpry@ucdavis.edu. | |
dc.contributor.affiliation | California Department of Public Health, Richmond, CA, USA. | |
dc.contributor.affiliation | CIDRZ | |
dc.contributor.affiliation | Centre for Infectious Disease Research in Zambia (CIDRZ) | |
dc.contributor.author | Pry JM | |
dc.contributor.author | McCullough K | |
dc.contributor.author | Lai KW | |
dc.contributor.author | Lim E | |
dc.contributor.author | Mehrotra ML | |
dc.contributor.author | Lamba K | |
dc.contributor.author | Jain S | |
dc.date.accessioned | 2025-05-23T11:42:02Z | |
dc.date.issued | 2024-Dec-02 | |
dc.description.abstract | BACKGROUND: More than four years after the start of the COVID-19 pandemic, understanding of SARS-CoV-2 burden and post-acute sequela of COVID (PASC), or long COVID, continues to evolve. However, prevalence estimates are disparate and uncertain. Leveraging survey responses from a large serosurveillance study, we assess prevalence estimates using five different long COVID definitions among California residents. METHODS: The California Department of Public Health (CDPH) conducted a cross-sectional survey that included questions about acute COVID-19 infection and recovery. A random selection of California households was invited to participate in a survey that included demographic information, clinical symptoms, and COVID-19 vaccination history. We assessed prevalence and predictors of long COVID among those previously testing positive for SARS-CoV-2 across different definitions using logistic regression. FINDINGS: A total of 2883 participants were included in this analysis; the majority identified as female (62.5 %), and the median age was 39 years (interquartile range: 17-55 years). We found a significant difference in long COVID prevalence across definitions with the highest prevalence observed when participants were asked about incomplete recovery (20.9 %, 95 % confidence interval [CI]: 19.4-22.5) and the lowest prevalence was associated with severe long COVID affecting an estimated 4.9 % (95 % CI 4.1-5.7) of the participant population. Individuals that completed the primary vaccination series had significantly lower prevalence of long COVID compared to those that did not receive COVID vaccination. INTERPRETATION: There were significant differences in the estimated prevalence of long COVID across different definitions. People who experience a severe initial COVID-19 infection should be considered at a higher probability for developing long COVID. FUNDING: Centers for Disease Control and Prevention - Epidemiology and Laboratory Capacity. | |
dc.identifier.doi | 10.1016/j.vaccine.2024.126358 | |
dc.identifier.uri | https://pubs.cidrz.org/handle/123456789/10602 | |
dc.source | Vaccine | |
dc.title | Defining long COVID using a population-based SARS-CoV-2 survey in California. |